STING1 and cancer: In cancer, the intrinsic anti-tumor immune efficiency of the cGAS-STING signal pathway inspires intense efforts to boost anti-tumor immunity in next-generation cancer immunotherapies by developing cGAS-STING signal pathway agonists.